Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney, Emily Graffeo, and Alexis Christoforous

-Matthew Bloxham, Bloomberg Intelligence Senior and Tech Analyst, discusses Bill Ackman's investment firm Pershing Square Capital Management pitching a deal to combine Universal Music Group with an acquisition vehicle publicly traded in the US.

-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Broadcom. Anthropic confirmed plans to work with Broadcom and Google to power its operations.

-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Gilead Sciences agreed to buy private German biotech Tubulis GmbH in a deal worth up to $5 billion to boost its portfolio in cancer drug development.  Novo Nordisk will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival Eli Lilly & Co.’s Zepbound.

-Lloyd Arnold, BNEF Data Center Reporter, discusses data centers. The digital infrastructure boom is continuing apace despite jitters in equity markets and fears of a “bubble”. The capital expenditure of the 14 largest publicly owned data center operators globally is seen close to $750 billion this year against a little less than $450 billion last year. 

Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Bloomberg Intelligence hosted by Paul Sweeney, Emily Graffeo, and Alexis Christoforous -Matthew Bloxham, Bloomberg Intelligence Senior and Tech Analyst, discusses Bill Ackman's investment firm Pershing Square Capital Management pitching a deal to combine Universal Music Group with an acquisition vehicle publicly traded in the US. -Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Broadcom. Anthropic confirmed plans to work with Broadcom and Google to power its operations. -Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Gilead Sciences agreed to buy private German biotech Tubulis GmbH in a deal worth up to $5 billion to boost its portfolio in cancer drug development. &nbsp;Novo Nordisk will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival&nbsp;Eli Lilly &amp; Co.&rsquo;s Zepbound.
-Lloyd Arnold, BNEF Data Center Reporter, discusses data centers. The digital infrastructure boom is continuing apace despite jitters in equity markets and fears of a &ldquo;bubble&rdquo;. The capital expenditure of the 14 largest publicly owned data center operators globally is seen close to $750 billion this year against a little less than $450 billion last year.&nbsp;

Listen for investment news and in-depth company research. 

Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: http://bit.ly/3vTiACF.

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Ackman Pitches $65 Billion UMG Deal to Move Listing to US 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4d27adaf-787f-40c0-9848-b4250114fdab/transcript